Novel stem cell therapy approach proves effective in treating COVID-19
An international team of researchers has advanced a new therapeutic approach using stem cells to treat COVID-19.
Psychological impacts of Delta
Languishing, burnout and stigma are all among the possible psychological impacts as Delta lingers in the community, says Dr Dougal Sutherland.
What to expect in the vaccine rollout
News that the Government has now secured agreements to purchase 15 million doses of Covid-19 vaccine (all going well) means that while 2021 will not be easy...
Online ‘echo chamber’ can lead to COVID-19 vaccine hesitancy
Government and social media firms need to take urgent action, according to a new study from the universities of Oxford and Southampton which finds that people who look to social media for information...
Researchers at University of Toronto, McMaster study COVID-19 testing protocols for arriving international travellers
McMaster HealthLabs, a COVID-19-focused non-profit organization associated with researchers at McMaster University, the Research Institute of St. Joe’s Hamilton...
University of Bristol students launch international charity scheme
A scheme set up by five University of Bristol undergraduates has begun to support charities across the globe during the COVID-19 pandemic.
Free NHS coronavirus tests available to all King’s students and staff
Anyone can be a carrier of the COVID-19 virus without experiencing any symptoms and taking a Lateral Flow test is a quick and rapid way to detect the virus without...
Coronavirus update: London to enter Tier 3 restrictions
The UK Government has announced that London will move from Tier 2 to Tier 3 COVID-19 restrictions from Wednesday 16 December.
HKBU deploys new AI-enhanced COVID-19 alert system
Researchers at Hong Kong Baptist University (HKBU) have integrated artificial intelligence (AI) technology with BU-Trace, the COVID-19 alert system (the System) they have developed.
University of Alberta lab reveals how a much-needed oral antiviral drug confuses the replication...
A University of Alberta virology lab has uncovered how an oral antiviral drug works to attack the SARS-CoV-2 virus, in findings published May 10 in the Journal of Biological Chemistry.
